Market Currents
Shares of Allos Therapeutics (ALTH) move up 8.1% premarket on chatter that the firm could be a...
-
Tuesday, January 31, 2012, 8:20 AM ETShares of Allos Therapeutics (ALTH) move up 8.1% premarket on chatter that the firm could be a beneficiary of the decision by Cell Therapeutics (CTIC) to withdraw its NDA with the FDA.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
